Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
4528:TYO
Ono Pharmaceutical Co Ltd
¥2,304.50
-1.94%
(-45.50) 1D
Apr 27, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4528...
Open
¥2,321
High
¥2,326
Low
¥2,294
Mkt. cap
1.15T
Avg. vol.
1.81M
Volume
1.17M
Dividend
3.47%
Quarterly dividend
¥20
Ex dividend date
Sep 29, 2025
P/E ratio
17.36
52-wk high
¥2,674
52-wk low
¥1,474
EPS
¥133
Shares outstanding
514.12M
No. of employees
4K
News stories
From sources across the web
Profile
Ono Pharmaceutical Co., Ltd. is one of the largest pharmaceutical companies in Japan. It is headquartered in Chuo-ku, Osaka, Japan, with its major plants in Higashinari-ku, Osaka, and Fujinomiya, Shizuoka., and its central research institute at Minase, Shimamoto-cho, Mishima District, Osaka. Ono Pharmaceutical's roots go back to 1717 when Ichibei Ono started his dealer business of pharmaceuticals in Osaka. His business expanded and changed its name a few times, and became Ono Pharmaceutical Industrial Co., Ltd. in 1948. Ono has been listed in Tokyo Stock Exchange since 1963. Its consolidated earnings in the half year ending in March 2018 were 16 billion Japanese yen. Nivolumab, the cancer drug based on the research of Prof. Dr. Tasuku Honjo of Kyoto University, who received the Nobel Prize later in 2018, is marketed by both Ono Pharmaceutical and Bristol-Myers Squibb. In 2024, Harvard University and Ono Pharmaceutical entered into a joint research and drug development agreement. Under it, promising projects to test therapeutic targets will be selected over 5 years under the guidance of Harvard's Office of Technology Development, and ONO will fund the work. Wikipedia
About Ono Pharmaceutical Co Ltd
CEOGyo Sagara | Gyo Sagara
Employees4.29K
Founded1717
HeadquartersOsaka, Osaka, Japan
SectorPharmaceutical industry
Websiteono-pharma.com
Last report
Feb 1, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -JPY
Revenue / Estimate
139.90B/ (129.40B est.)JPY
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
112.31B
127.54B
129.60B
139.90B
Cost of goods sold
45.24B
37.01B
34.96B
36.68B
Cost of revenue
45.24B
37.01B
34.96B
36.68B
Research and development expenses
46.30B
36.25B
34.77B
33.53B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31.86B
31.09B
30.08B
31.73B
Operating expense
82.93B
68.53B
64.56B
67.00B
Total operating expenses
128.16B
105.54B
99.53B
103.68B
Operating income
-15.85B
22.00B
30.07B
36.22B
Other non operating income
21.00M
-
-
-
EBT including unusual items
-12.71B
22.65B
29.52B
37.20B
EBT excluding unusual items
-15.67B
22.65B
29.52B
37.20B
Income tax expense
-6.34B
5.02B
7.17B
8.31B
Effective tax rate
49.90%
22.16%
24.30%
22.35%
Other operating expenses
1.31B
1.19B
-291.00M
1.73B
Net income
-6.54B
17.67B
22.42B
28.86B
Net profit margin
-5.83%
13.86%
17.30%
20.63%
Earnings per share
-
-
-
-
Interest and investment income
1.90B
1.43B
677.00M
1.39B
Interest expense
-
-773.00M
-1.23B
-408.00M
Net interest expenses
1.90B
655.00M
-549.00M
979.00M
Depreciation and amortization charges
3.45B
-
-
-
EBITDA
-7.13B
31.23B
39.39B
45.82B
Gain or loss from assets sale
7.98B
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer